AI takes on pap smears: could it match human experts?

NCT ID NCT06767111

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study compares a new AI-assisted digital system to the standard manual method for reading Pap tests. About 4,600 cervical cell samples will be reviewed both ways to see if the AI system is just as good at detecting abnormal cells. The goal is to determine if the AI can help cytotechnologists work more efficiently without sacrificing accuracy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Techcyte SureView Cervical Cytology System (AI-assisted digital imaging device)

What this could lead to

If successful, this could provide a faster, AI-assisted way to read Pap tests that is as accurate as the current manual method, potentially improving lab efficiency.

What could go wrong

This is a large study but still testing a new device; it may not prove non-inferior to standard practice, and AI-assisted reading could miss abnormalities or increase false positives.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CYTOLOGY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Techcyte

    Orem, Utah, 84057, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.